Artiam Bio
Artiam Bio is a biotechnology focused on the development of second-generation type 1 cannabinoid receptor antagonists for the treatment.
Operating in biotechnology, health care based in Research Triangle, East Coast, Southern US, Artiam Bio was founded in 2020.
The company sits in the biotechnology, health care segment, where it competes on its core product or service.
Its base of operations is Research Triangle, East Coast, Southern US.
Directory data places it at the Grant stage.
The company reports a headcount in the c_00001_00010 range.
Public records show total funding of about $71K.
| Sector | Biotechnology, Health Care |
|---|---|
| Headquarters | Research Triangle, East Coast, Southern US |
| Founded | 2020 |
| Employees | c_00001_00010 |
| Stage | grant |
| Total funding | $70,708 |
Website: artiambio.net
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account